---
layout: post
title: "Prospective Grant of an Exclusive Patent License: AAV Mediated Exendin-4 Gene Transfer to Salivary Glands To Protect Subjects From Diabetes or Obesity"
date: 2026-02-05 19:09:24 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2020-07706
original_published: 2020-04-13 00:00:00 +0000
significance: 8.00
---

# Prospective Grant of an Exclusive Patent License: AAV Mediated Exendin-4 Gene Transfer to Salivary Glands To Protect Subjects From Diabetes or Obesity

**Published:** February 05, 2026 19:09 UTC
**Source:** Federal Register
**Original Published:** April 13, 2020 00:00 UTC
**Document Number:** 2020-07706

## Summary

The National Institute of Diabetes and Digestive and Kidney Disease and National Institute of Dental and Craniofacial Research, institutes of the National Institutes of Health, Department of Health and Human Services, are contemplating the grant of an Exclusive Patent License to practice the inventions embodied in the United States, European and Canadian Applications listed in the Supplementary Information section of this notice to Kriya Therapeutics, Inc., located in Palo Alto, California, USA.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2020/04/13/2020-07706/prospective-grant-of-an-exclusive-patent-license-aav-mediated-exendin-4-gene-transfer-to-salivary)
- API: https://www.federalregister.gov/api/v1/documents/2020-07706

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
